The field of congenital interventional cardiology has experienced tremendous growth in
recent years. Beginning with the development of early devices for transcatheter closure of …

Transcatheter closure has been widely accepted as a highly effective way to treat abnormal
blood flows and/or embolization of thrombus in the heart. It allows the closure of four types of …

Abstract Purpose of Review The goal of this paper is to review currently available devices for
closure of atrial septal defects (ASDs) and ventricular septal defects (VSDs). Recent …

Over the past seven decades, significant advancements and innovations have occurred in
the field of percutaneous atrial septal defect (ASD) closure using transcatheter-based …

Background This perspective, observational study evaluated safety and efficacy of the
GORE® Cardioform ASD Occluder (WL Gore & Associates, Flagstaff, AZ), compliant and …

Patients with congenital heart disease now live well into adulthood because of advances in
surgical techniques, improvements in medical management, and the development of novel …

Abstract Background The GORE CARDIOFORM ASD Occluder (GCA, WL Gore &
Associates) was approved in 2019 for ostium secundum atrial septal defect (ASD) closure …

Background and aim: The GORE® CARDIOFORM (GCO) septal occluder is an atrial septal
defect/patent foramen ovale closure device with theoretical advantages over other …

Background The GCA is a well performing device in terms of efficacy despite complex
anatomies (aortic rim< 5 mm and ASD diameter> 17 mm) with a good safety profile. Aims To …

The GORE CARDIOFORM atrial septal defect (ASD) Occluder (GCA) is composed of a
platinum-filled nitinol wire frame covered with expanded polytetrafluoroethylene, making it …